Literature DB >> 15953493

Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm.

Tanja Jovanovic1, Megan Keyes, Ana Fiallos, Karyn M Myers, Michael Davis, Erica J Duncan.   

Abstract

BACKGROUND: The inability to suppress excessive fear or anxiety is a significant clinical problem. In the laboratory, extinction is a preferred method for the study of fear inhibition; however, in this paradigm the same stimulus causes both elicitation (excitation) and inhibition of fear, making it difficult to know whether an experimental manipulation that affects extinction does so by affecting one or both of these processes. For this reason, we sought to develop a behavioral procedure in humans that would render a stimulus primarily inhibitory.
METHODS: We adapted a conditional discrimination procedure (AX+/BX-), previously validated in animals, to a human fear-potentiated startle paradigm. Forty-one healthy volunteers were presented with one set of colored lights paired with the delivery of aversive airblasts to the throat (AX+) and a different series of lights presented without airblasts (BX-).
RESULTS: Participants exhibited fear potentiation to AX+, discrimination between AX+ and BX-, and transfer of fear inhibition to A in an AB compound test but not in an AC compound test.
CONCLUSIONS: We believe this procedure will advance clinical research on fear disorders, such as posttraumatic stress disorder and phobias, by providing an effective and relatively independent measure of fear potentiation and fear inhibition.

Entities:  

Mesh:

Year:  2005        PMID: 15953493     DOI: 10.1016/j.biopsych.2005.02.025

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  60 in total

1.  Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.

Authors:  Tanja Jovanovic; Erica J Duncan; Joanna Kaye; Kristie Garza; Seth D Norrholm; Sabra S Inslicht; Thomas C Neylan; Sanjay J Mathew; Dan Iosifescu; Barbara O Rothbaum; Helen S Mayberg; Boadie W Dunlop
Journal:  Psychophysiology       Date:  2019-02-26       Impact factor: 4.016

Review 2.  Impaired safety signal learning may be a biomarker of PTSD.

Authors:  Tanja Jovanovic; Andrew Kazama; Jocelyne Bachevalier; Michael Davis
Journal:  Neuropharmacology       Date:  2011-03-04       Impact factor: 5.250

Review 3.  Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder.

Authors:  Kevin Sean Murnane
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

Review 4.  Inhibition of fear by learned safety signals: a mini-symposium review.

Authors:  John P Christianson; Anushka B P Fernando; Andy M Kazama; Tanja Jovanovic; Linnaea E Ostroff; Susan Sangha
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

5.  Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm.

Authors:  Tanja Jovanovic; Seth D Norrholm; Megan Keyes; Ana Fiallos; Sasa Jovanovic; Karyn M Myers; Michael Davis; Erica J Duncan
Journal:  Behav Neurosci       Date:  2006-10       Impact factor: 1.912

Review 6.  From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.

Authors:  Michael B VanElzakker; M Kathryn Dahlgren; F Caroline Davis; Stacey Dubois; Lisa M Shin
Journal:  Neurobiol Learn Mem       Date:  2013-12-07       Impact factor: 2.877

Review 7.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

8.  Acute stress disorder versus chronic posttraumatic stress disorder: inhibition of fear as a function of time since trauma.

Authors:  Tanja Jovanovic; Andrea Jambrošić Sakoman; Dragica Kozarić-Kovačić; Ana Havelka Meštrović; Erica J Duncan; Michael Davis; Seth D Norrholm
Journal:  Depress Anxiety       Date:  2012-08-20       Impact factor: 6.505

9.  Inhibition of fear is differentially associated with cycling estrogen levels in women.

Authors:  Ebony M Glover; Kristina B Mercer; Seth D Norrholm; Michael Davis; Erica Duncan; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

10.  Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans.

Authors:  Seth D Norrholm; Bram Vervliet; Tanja Jovanovic; William Boshoven; Karyn M Myers; Michael Davis; Barbara Rothbaum; Erica J Duncan
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.